2024-05-25 03:01:27 ET
Summary
- Myomo is a wearable medical robotics company that designs and manufactures orthotics for people with neurological disorders.
- The company's stock performance has been disappointing, losing almost all of its value since going public in 2017.
- Despite this, MYO has gained momentum in the past year and is expected to benefit from recent policy changes by CMS, presenting a buying opportunity.
Myomo ( MYO ) is a wearable medical robotics company designing, developing, and manufacturing myoelectric orthotics for people suffering from neurological disorders. Its brace is mainly used to offer expanded mobility for stroke survivor’s paralyzed arms....
Read the full article on Seeking Alpha
For further details see:
Myomo: TAM Expansion Opportunity From Policy Tailwinds